GL1X · GenesisL1 explorer

MolNFT v1 · #105056 · protein

Structure of human haspin (GSG2) in complex with SCH772984 revealing the first type-I binding mode

4QTC · SERINE/THREONINE-protein kinase haspin: “Structure of human haspin (GSG2) in complex with SCH772984 revealing the first type-I binding mode”. X-ray diffraction, 1 ligand (38Z), 1 pocket (best druggability 0.68). MolNFT v1 #105056 on…

PDB
4QTC
Type
protein
Length
330 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase haspin
EC
2.7.11.1
UniProt
Q8TF76
Ligands
38Z
Pockets
1 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase haspin (EC 2.7.11.1)protein33038% helix, 24% strandQ8TF76

Ligands and binding sites

  • 38Z · (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14240.680.805138Z

Compared structures

  • 4QTC · Structure of human haspin (GSG2) in complex with SCH772984 revealing the first type-I… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8TF76 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase haspin (Q8TF76) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.